Capabilities · Concept
AI-Assisted Design of Biologic Medicines
Industry-science trend using AI to accelerate engineered-protein drug design amid high failure costs.
Connections
Connections · 2
How this node ties into the rest of the map, and the evidence behind each link.
Broader AI-for-science medicine design wave aligns with frontier labs’ science tooling and grant programs.
+4 growthBoth reflect industry/science use of frontier AI to accelerate biomedical discovery and therapeutic design.
+3 growthSignal sources
Signal sources
Dated facts from primary sources in this direction.
The length of software tasks AI agents can do autonomously at 50% reliability has doubled about every 7 months — and since 2024 closer to every ~3 months.
METR →In one year scores rose by 18.8, 48.9 and 67.3 points on MMMU, GPQA and SWE-bench; real-world software solve rate jumped from 4.4% to 71.7%.
Stanford HAI — AI Index 2025 →On SWE-bench Verified (500 real GitHub issues), autonomous coding agents reached ~80–86% by late 2025, up from under 50% in early 2025.
Epoch AI →